Related Experiment Video
Updated: Jan 23, 2026

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats
Published on: February 14, 2022
Understanding Atrial Cardiopathy: an Under-Recognized Contributor to Cardioembolic Stroke
Michelle C Johansen1, Henrique Doria De Vasconcellos2, Rebecca F Gottesman3
1Department of Neurology, The Johns Hopkins University School of Medicine, 600 N. Wolfe Street, Phipps 4 Suite 446, Baltimore, MD, 21287, USA. mjohans3@jhmi.edu.
Insights
Cardioembolic stroke (CES) is a major cause of death, often linked to atrial fibrillation (AF). This review covers CES diagnosis, treatment, and future research directions for better patient outcomes.
Area of Science:
- Neurology
- Cardiology
- Public Health
Background:
- Ischemic stroke is a leading global cause of death.
- Cardioembolic stroke (CES), primarily caused by atrial fibrillation (AF), contributes significantly to stroke morbidity and mortality.
- The incidence of CES is expected to increase with an aging population.
Purpose of the Study:
- To review current knowledge on the diagnosis and treatment of CES.
- To discuss novel therapeutic options for CES.
- To highlight areas for future research, including atrial cardiopathy.
Main Methods:
- Literature review of recent advancements in CES and AF management.
- Analysis of current treatment guidelines and emerging therapeutic strategies.
- Identification of knowledge gaps in the diagnosis and treatment of embolic strokes of unknown source.
Main Results:
- Significant advancements in monitoring and diagnosing AF have occurred.
- Optimal secondary stroke prevention in AF patients with anticoagulation is established.
- The management of embolic strokes without a clear source remains an area requiring further definition.
Conclusions:
- Effective management of CES, particularly in the context of AF, is crucial.
- Novel therapeutics are emerging for CES treatment.
- Future research should focus on understanding conditions like atrial cardiopathy to improve CES management.
Purpose Of Review:
Ischemic stroke is the fifth leading cause of death in the world with cardioembolic stroke (CES) causing a disproportional amount of the morbidity and mortality associated with stroke. Atrial fibrillation (AF) is the leading cause of CES, and as the population ages, the incidence of CES is anticipated to rise. The importance of proper diagnosis and treatment of patients with embolic-appearing stroke is significant due to the burden of disease and the severity of the illness.
Recent Findings:
The past decade has seen an explosion of treatment options for patients with CES related to AF as well as better mechanisms by which to monitor and diagnose patients with AF. While optimal secondary prevention of stroke with anticoagulation in the setting of AF is known, what remains to be defined is the appropriate treatment of other types of strokes that appear embolic, but no source of the embolism is discovered. In this article, we will review what is known about the diagnosis and treatment of CES, discuss the emergence of novel therapeutics and emphasize what must be investigated in the future to move the field forward, such as the emerging concept of atrial cardiopathy.
Related Concept Videos
Understanding the Self
Understanding Memory
Understanding Love
Understanding Consciousness
Sleep, a crucial state, is characterized by reduced...
Understanding Sleep
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...
Understanding Self-Concept

